AAAAAA

   
Results: 1-25 | 26-28
Results: 1-25/28
ACTIVATION OF COAGULATION AND ANGIOGENESIS IN CANCER - IMMUNOHISTOCHEMICAL LOCALIZATION IN-SITU OF CLOTTING PROTEINS AND VASCULAR ENDOTHELIAL GROWTH-FACTOR IN HUMAN CANCER
Authors: SHOJI M HANCOCK WW ABE K MICKO C CASPER KA BAINE RM WILCOX JN DANAVE I DILLEHAY DL MATTHEWS E CONTRINO J MORRISSEY JH GORDON S EDGINGTON TS KUDRYK B KREUTZER DL RICKLES FR
Citation: M. Shoji et al., ACTIVATION OF COAGULATION AND ANGIOGENESIS IN CANCER - IMMUNOHISTOCHEMICAL LOCALIZATION IN-SITU OF CLOTTING PROTEINS AND VASCULAR ENDOTHELIAL GROWTH-FACTOR IN HUMAN CANCER, The American journal of pathology, 152(2), 1998, pp. 399-411
MOLECULAR MECHANISMS LINKING THROMBOSIS AND ANGIOGENESIS IN CANCER
Authors: SHOJI M ABE K NAWROTH PP RICKLES FR
Citation: M. Shoji et al., MOLECULAR MECHANISMS LINKING THROMBOSIS AND ANGIOGENESIS IN CANCER, Trends in cardiovascular medicine, 7(2), 1997, pp. 52-59
FIBRIN INDUCTION OF TISSUE FACTOR EXPRESSION IN HUMAN VASCULAR ENDOTHELIAL-CELLS
Authors: CONTRINO J GORALNICK S QI JF HAIR G RICKLES FR KREUTZER DL
Citation: J. Contrino et al., FIBRIN INDUCTION OF TISSUE FACTOR EXPRESSION IN HUMAN VASCULAR ENDOTHELIAL-CELLS, Circulation, 96(2), 1997, pp. 605-613
THE PROCOAGULANT EFFECT OF HOMOCYSTEINE ON THE HUMAN HEPG-2 HEPATOMA-CELLS
Authors: PHILLIPS DJ RENSHAW M EVATT BL RICKLES FR HOOPER WC
Citation: Dj. Phillips et al., THE PROCOAGULANT EFFECT OF HOMOCYSTEINE ON THE HUMAN HEPG-2 HEPATOMA-CELLS, Blood, 90(10), 1997, pp. 3159-3159
TISSUE FACTOR EXPRESSION IN NORMAL AND ABNORMAL MAMMARY-GLAND - REPLY
Authors: RICKLES FR CONTRINO J KREUTZER DL
Citation: Fr. Rickles et al., TISSUE FACTOR EXPRESSION IN NORMAL AND ABNORMAL MAMMARY-GLAND - REPLY, Nature medicine, 2(5), 1996, pp. 491-492
IN-SITU DETECTION OF TISSUE FACTOR IN VASCULAR ENDOTHELIAL-CELLS - CORRELATION WITH THE MALIGNANT PHENOTYPE OF HUMAN BREAST DISEASE
Authors: CONTRINO J HAIR G KREUTZER DL RICKLES FR
Citation: J. Contrino et al., IN-SITU DETECTION OF TISSUE FACTOR IN VASCULAR ENDOTHELIAL-CELLS - CORRELATION WITH THE MALIGNANT PHENOTYPE OF HUMAN BREAST DISEASE, Nature medicine, 2(2), 1996, pp. 209-215
TISSUE FACTOR EXPRESSION IN HUMAN LEUKEMIC-CELLS
Authors: HAIR GA PADULA S ZEFF R SCHMEIZL M CONTRINO J KREUTZER DL DEMOERLOOSE P BOYD AW STANLEY I BURGESS AW RICKLES FR
Citation: Ga. Hair et al., TISSUE FACTOR EXPRESSION IN HUMAN LEUKEMIC-CELLS, Leukemia research, 20(1), 1996, pp. 1-11
PRETREATMENT FIBRINOGEN LEVELS ARE ASSOCIATED WITH RESPONSE TO CHEMOTHERAPY IN PATIENTS WITH SMALL-CELL CARCINOMA OF THE LUNG - DEPARTMENT-OF-VETERANS-AFFAIRS COOPERATIVE STUDY-188
Authors: MEEHAN KR ZACHARSKI LR MORITZ TE RICKLES FR
Citation: Kr. Meehan et al., PRETREATMENT FIBRINOGEN LEVELS ARE ASSOCIATED WITH RESPONSE TO CHEMOTHERAPY IN PATIENTS WITH SMALL-CELL CARCINOMA OF THE LUNG - DEPARTMENT-OF-VETERANS-AFFAIRS COOPERATIVE STUDY-188, American journal of hematology, 49(2), 1995, pp. 143-148
COMPARISON OF 6 COMMERCIAL PLASMA REFERENCES FOR FACTOR-VIII, FACTOR-IX AND VON-WILLEBRAND-FACTOR - ON BEHALF OF THE SUBCOMMITTEE FOR FACTOR-VIII AND IX OF THE SCIENTIFIC AND STANDARDIZATION COMMITTEE OF THE ISTH
Authors: KASPER CK ARONSON DL DAVIGNON G FOSTER P HILLMANWISEMAN C LUSHER JM MANCOJOHNSON M MEADE JB MONTGOMERY RR RICKLES FR WHITE GC
Citation: Ck. Kasper et al., COMPARISON OF 6 COMMERCIAL PLASMA REFERENCES FOR FACTOR-VIII, FACTOR-IX AND VON-WILLEBRAND-FACTOR - ON BEHALF OF THE SUBCOMMITTEE FOR FACTOR-VIII AND IX OF THE SCIENTIFIC AND STANDARDIZATION COMMITTEE OF THE ISTH, Thrombosis and haemostasis, 74(3), 1995, pp. 987-989
TISSUE FACTOR EXPRESSION IN HUMAN-LEUKOCYTES AND TUMOR-CELLS
Authors: RICKLES FR HAIR GA ZEFF RA LEE E BONA RD
Citation: Fr. Rickles et al., TISSUE FACTOR EXPRESSION IN HUMAN-LEUKOCYTES AND TUMOR-CELLS, Thrombosis and haemostasis, 74(1), 1995, pp. 391-395
FIBRIN INDUCTION OF TISSUE FACTOR EXPRESSION IN HUMAN VASCULAR ENDOTHELIAL-CELLS
Authors: CONTRINO J GORALNICK S HAIR G KREUTZER DL RICKLES FR
Citation: J. Contrino et al., FIBRIN INDUCTION OF TISSUE FACTOR EXPRESSION IN HUMAN VASCULAR ENDOTHELIAL-CELLS, Thrombosis and haemostasis, 73(6), 1995, pp. 910-910
THROMBOTIC THROMBOCYTOPENIC PURPURA IN PREGNANCY - SUCCESSFUL TREATMENT WITH PLASMA-EXCHANGE - CASE-REPORT AND REVIEW OF THE LITERATURE
Authors: MOKRZYCKI MH RICKLES FR KAPLAN AA KOHN OF
Citation: Mh. Mokrzycki et al., THROMBOTIC THROMBOCYTOPENIC PURPURA IN PREGNANCY - SUCCESSFUL TREATMENT WITH PLASMA-EXCHANGE - CASE-REPORT AND REVIEW OF THE LITERATURE, Blood purification, 13(5), 1995, pp. 271-282
RECURRENT VENOUS THROMBOSIS AS THE PRESENTING MANIFESTATION OF ACUTE LYMPHOCYTIC-LEUKEMIA - LEUKEMIC-CELL PROCOAGULANT ACTIVITY IS NOT RESPONSIBLE FOR THE HYPERCOAGULABLE STATE
Authors: BILGRAMI S GREENBERG BR WEINSTEIN RE HAIR GA RICKLES FR
Citation: S. Bilgrami et al., RECURRENT VENOUS THROMBOSIS AS THE PRESENTING MANIFESTATION OF ACUTE LYMPHOCYTIC-LEUKEMIA - LEUKEMIC-CELL PROCOAGULANT ACTIVITY IS NOT RESPONSIBLE FOR THE HYPERCOAGULABLE STATE, Medical and pediatric oncology, 24(1), 1995, pp. 40-45
ACQUIRED ANTITHROMBIN-III DEFICIENCY - RATIONALE FOR REPLACEMENT THERAPY - INTRODUCTION AND OVERVIEW - WHAT ARE THE QUESTIONS
Authors: RICKLES FR
Citation: Fr. Rickles, ACQUIRED ANTITHROMBIN-III DEFICIENCY - RATIONALE FOR REPLACEMENT THERAPY - INTRODUCTION AND OVERVIEW - WHAT ARE THE QUESTIONS, Blood coagulation & fibrinolysis, 5, 1994, pp. 190000003-190000004
THE USE OF INTERMEDIATE AND HIGH-PURITY FACTOR-VIII PRODUCTS IN THE TREATMENT OF VON-WILLEBRAND DISEASE
Authors: HANNA WT BONA RD ZIMMERMAN CE CARTA CA HEBERT GZ RICKLES FR
Citation: Wt. Hanna et al., THE USE OF INTERMEDIATE AND HIGH-PURITY FACTOR-VIII PRODUCTS IN THE TREATMENT OF VON-WILLEBRAND DISEASE, Thrombosis and haemostasis, 71(2), 1994, pp. 173-179
COAGULATION ABNORMALITIES IN CANCER-PATIENTS - CLINICAL RELEVANCE
Authors: SPORN JR RICKLES FR
Citation: Jr. Sporn et Fr. Rickles, COAGULATION ABNORMALITIES IN CANCER-PATIENTS - CLINICAL RELEVANCE, Chest, 105(6), 1994, pp. 1639-1639
N-LINKED GLYCOSYLATION IS REQUIRED FOR MEMBRANE EXPRESSION OF CELLULAR TISSUE FACTOR
Authors: HAIR GA SCHMEIZL M DISTASIO D ZEFF R RICKLES FR
Citation: Ga. Hair et al., N-LINKED GLYCOSYLATION IS REQUIRED FOR MEMBRANE EXPRESSION OF CELLULAR TISSUE FACTOR, Clinical research, 42(2), 1994, pp. 10000183-10000183
IN-SITU CHARACTERIZATION OF ANTIGENIC AND FUNCTIONAL TISSUE FACTOR EXPRESSION IN HUMAN TUMORS UTILIZING MONOCLONAL-ANTIBODIES AND RECOMBINANT FACTOR VIIA AS PROBES
Authors: CONTRINO J HAIR GA SCHMEIZL MA RICKLES FR KREUTZER DL
Citation: J. Contrino et al., IN-SITU CHARACTERIZATION OF ANTIGENIC AND FUNCTIONAL TISSUE FACTOR EXPRESSION IN HUMAN TUMORS UTILIZING MONOCLONAL-ANTIBODIES AND RECOMBINANT FACTOR VIIA AS PROBES, The American journal of pathology, 145(6), 1994, pp. 1315-1322
NEW INSIGHTS INTO THE PATHOGENESIS OF COAGULATION DYSFUNCTION IN ACUTE PROMYELOCYTIC LEUKEMIA
Authors: TALLMAN MS HAKIMIAN D KWAAN HC RICKLES FR
Citation: Ms. Tallman et al., NEW INSIGHTS INTO THE PATHOGENESIS OF COAGULATION DYSFUNCTION IN ACUTE PROMYELOCYTIC LEUKEMIA, Leukemia & lymphoma, 11(1-2), 1993, pp. 27-36
GUIDELINES FOR CLOTTING STUDIES IN CANCER-PATIENTS
Authors: FALANGA A BARBUI T RICKLES FR LEVINE MN
Citation: A. Falanga et al., GUIDELINES FOR CLOTTING STUDIES IN CANCER-PATIENTS, Thrombosis and haemostasis, 70(3), 1993, pp. 540-542
REGISTRY OF CLINICAL-TRIALS OF ANTITHROMBOTIC DRUGS IN CANCER - 2ND REPORT - THE SCIENTIFIC AND STANDARDIZATION COMMITTEE OF THE INTERNATIONAL-SOCIETY-ON-THROMBOSIS-AND-HEMOSTASIS SUBCOMMITTEE-ON-HEMOSTASIS-AND-MALIGNANCY
Authors: ZACHARSKI LR DONATI MB RICKLES FR
Citation: Lr. Zacharski et al., REGISTRY OF CLINICAL-TRIALS OF ANTITHROMBOTIC DRUGS IN CANCER - 2ND REPORT - THE SCIENTIFIC AND STANDARDIZATION COMMITTEE OF THE INTERNATIONAL-SOCIETY-ON-THROMBOSIS-AND-HEMOSTASIS SUBCOMMITTEE-ON-HEMOSTASIS-AND-MALIGNANCY, Thrombosis and haemostasis, 70(2), 1993, pp. 357-360
ALL-TRANS-RETINOIC ACID (ATRA) INHIBITS THE EXPRESSION OF TISSUE FACTOR IN HUMAN PROGRANULOCYTIC LEUKEMIA-CELLS
Authors: RICKLES FR HAIR G SCHMEIZL M KWAAN H LANOTTE M TALLMAN M
Citation: Fr. Rickles et al., ALL-TRANS-RETINOIC ACID (ATRA) INHIBITS THE EXPRESSION OF TISSUE FACTOR IN HUMAN PROGRANULOCYTIC LEUKEMIA-CELLS, Thrombosis and haemostasis, 69(6), 1993, pp. 573-573
FIBRINOPEPTIDE-A (FPA) AND FIBRINOPEPTIDE-B (FPB) INDUCED TISSUE FACTOR AND PLASMINOGEN-ACTIVATOR EXPRESSION IN HUMAN VASCULAR ENDOTHELIAL-CELLS (HUVEC) IN-VITRO
Authors: CONTRINO J HEBERT G SCHMEIZL M HAIR G RICKLES FR KREUTZER DL
Citation: J. Contrino et al., FIBRINOPEPTIDE-A (FPA) AND FIBRINOPEPTIDE-B (FPB) INDUCED TISSUE FACTOR AND PLASMINOGEN-ACTIVATOR EXPRESSION IN HUMAN VASCULAR ENDOTHELIAL-CELLS (HUVEC) IN-VITRO, Thrombosis and haemostasis, 69(6), 1993, pp. 1042-1042
DELAYED CORRECTION OF THE BLEEDING-TIME (BT) AFTER DDAVP IN QUALITATIVE PLATELET DEFECTS
Authors: BURROUGHS SF PANEK S BARTOLOMEO A RICKLES FR
Citation: Sf. Burroughs et al., DELAYED CORRECTION OF THE BLEEDING-TIME (BT) AFTER DDAVP IN QUALITATIVE PLATELET DEFECTS, Thrombosis and haemostasis, 69(6), 1993, pp. 1050-1050
PRODUCTION OF MODIFIED CROSS-LINKED CELL-FREE HEMOGLOBIN FOR HUMAN USE - THE ROLE OF QUANTITATIVE-DETERMINATION OF ENDOTOXIN CONTAMINATION
Authors: ROTH RI LEVIN J CHAPMAN KW SCHMEIZL M RICKLES FR
Citation: Ri. Roth et al., PRODUCTION OF MODIFIED CROSS-LINKED CELL-FREE HEMOGLOBIN FOR HUMAN USE - THE ROLE OF QUANTITATIVE-DETERMINATION OF ENDOTOXIN CONTAMINATION, Transfusion, 33(11), 1993, pp. 919-924
Risultati: 1-25 | 26-28